Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly
Results Non-lesional vitiligo melanocytes show increased expression of autophagic markers To investigate the possible involvement of autophagy in vitiligo, we initially determined the relative mRNA abundance of some Atg transcripts ( Atg5, Atg7, Atg8 ) by quantitative reverse-transcriptase PCR (Fig
It's the nerve impingement that creates the most debilitating effects
2012 Jul;134(2):709-17
US$ 22.39
US$ 27.04
US$ 20.00
US$ 24.84
US$ 20.35
US$ 28.95
US$ 23.01
US$ 28.88